{"nctId":"NCT00509106","briefTitle":"Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia","startDateStruct":{"date":"2007-07"},"conditions":["Bacterial Pneumonia"],"count":622,"armGroups":[{"label":"Ceftaroline fosamil for injection","type":"EXPERIMENTAL","interventionNames":["Drug: Ceftaroline fosamil for Injection"]},{"label":"IV Ceftriaxone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ceftriaxone","Drug: Placebo"]}],"interventions":[{"name":"Ceftaroline fosamil for Injection","otherNames":["Experimental"]},{"name":"Ceftriaxone","otherNames":["Active comparator"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nSubjects with community-acquired pneumonia requiring:\n\n* initial hospitalization or treatment in an emergency room or urgent care setting\n* infection requiring initial treatment with IV antimicrobial\n\nExclusion Criteria:\n\n* Community-acquired pneumonia suitable for outpatient therapy with an oral antimicrobial agent\n* Respiratory tract infections not due to community-acquired bacterial pathogens\n* Infections resistant to ceftriaxone\n* Any condition requiring concomitant systemic corticosteroids\n* History of any hypersensitivity or allergic reaction to any ÃŸ-lactam antimicrobial","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Clinical Cure Rate for Ceftaroline Compared to That for Ceftriaxone at the Test of Cure (TOC) in the Modified Intent to Treat Efficacy (MITTE) Population","description":"Cure:Total resolution of all signs and symptoms of pneumonia (ie,CABP), or improvement to such an extent that further antimicrobial therapy was not necessary\n\nFailure: Any of the following:\n\n* Persistence, incomplete clinical resolution, or worsening in signs and symptoms of CABP that required alternative antimicrobial therapy\n* Treatment-limiting adverse event (AE) leading to discontinuation of study drug therapy, when subject required alternative antimicrobial therapy to treat the pneumonia\n* Death wherein pneumonia (ie,CABP) was considered causative\n\nIndeterminate: Inability to determine an outcome","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"235","spread":null},{"groupId":"OG001","value":"206","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47","spread":null},{"groupId":"OG001","value":"56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"PRIMARY","title":"Clinical Cure Rate for Ceftaroline Compared With That for Ceftriaxone at TOC in the Clinically Evaluable (CE) Population","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Clinical Response at End of Therapy (EOT)","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Microbiological Success Rate at TOC","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Overall Clinical and Radiographic Success Rate at TOC","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Clinical and Microbiological Response by Pathogen at TOC","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Clinical Relapse at Late Follow Up (LFU) Visit","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Microbiological Reinfection/Recurrence at LFU","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Evaluate Safety","description":null,"paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":41,"n":315},"commonTop":["Diarrhea","Insomnia","Phlebitis","Headache","Hypertension"]}}}